{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:00Z","timestamp":1791908640329,"version":"4.3.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To assess the diagnostic accuracy of the free androgen index (FAI) in diagnosing polycystic ovary syndrome (PCOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We systematically searched PubMed, Cochrane Library, and Google Scholar databases for relevant studies published up to June 2024. The inclusion criteria were studies that reported the sensitivity and specificity of FAI for PCOS diagnosis. We used a random-effects model to find the pooled sensitivity, specificity, diagnostic odds ratio (DOR), and summary receiver operating characteristic area under the curve (SROC AUC). We determined positive and negative likelihood ratios (NLRs) using the Fagan nomogram and assessed heterogeneity using\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      statistics. We performed meta-regression and subgroup analysis to explore sources of heterogeneity and used Deeks\u2019 funnel plot to assess publication bias. This study is registered with PROSPERO (ID: CRD42024546829).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We included 14 studies with 2870 PCOS patients and 3985 non-PCOS controls. Pooled sensitivity and specificity were 0.81 (95% confidence interval [CI]; 0.73\u20130.86) and 0.82 (95% CI; 0.72\u20130.90), respectively. The positive and NLRs were 4.6 (95% CI; 2.8\u20137.6) and 0.23 (95% CI; 0.17\u20130.33), respectively. The DOR was 20 (95% CI: 10\u201339), and the SROC AUC was 0.88 (95% CI: 0.85\u20130.90). Variability in FAI cutoff values contributed significantly to heterogeneity across studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serum FAI is a reliable biomarker for diagnosing PCOS, demonstrating sensitivity and specificity exceeding 80%. It is particularly valuable in primary care settings where ultrasound facility is unavailable. FAI assists in diagnosing biochemical hyperandrogenism, especially in cases where clinical criteria are inconclusive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_306_24","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:10Z","timestamp":1744675210000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Accuracy of the Serum-free Androgen Index in Diagnosing Polycystic Ovary Syndrome: An Updated Systematic Review and Meta-analysis"],"prefix":"10.4103","volume":"25","author":[{"given":"Shishir","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divakar","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Kumar","family":"Niraj","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avijit","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hi-Tech Medical College and Hospital, Rourkela, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","article-title":"The role of genes and environment in the etiology of PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: A brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"Fauser","year":"2004","journal-title":"Hum Reprod"},{"key":"R10-20260109","first-page":"22","article-title":"Hyperandrogenism in women with polycystic ovarian syndrome: Pathophysiology and controversies","volume":"3","author":"Kanbour","year":"2022","journal-title":"Androgens"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective","volume":"101","author":"Pasquali","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2006-924062","article-title":"Is it necessary to measure free testosterone to assess hyperandrogenemia in women?The role of calculated free and bioavailable testosterone","volume":"114","author":"Mueller","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/000456328502200504","article-title":"The relationship between sex steroids and sex-hormone-binding globulin in plasma in physiological and pathological conditions","volume":"22","author":"Cunningham","year":"1985","journal-title":"Ann Clin Biochem"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/jog.14681","article-title":"The value of serum-free androgen index in the diagnosis of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"47","author":"Wang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1479-828X.1988.tb01668.x","article-title":"Which is the Best Test to Detect the Polycystic Ovary?","volume":"28","author":"Eden","year":"1988","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1991.tb00282.x","article-title":"The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: Predictive power of endocrine tests","volume":"34","author":"Fox","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R19-20260109","first-page":"173","article-title":"Is determination of the \u201cfree androgen index\u201d for hormone screening in polycystic ovaries of value?","volume":"33","author":"Steck","year":"1993","journal-title":"Gynakol Obstetrics Roundtable"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1450619","article-title":"Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies","author":"Escobar-Morreale","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1515\/CCLM.2007.031","article-title":"Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome","volume":"45","author":"Hahn","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5001\/omj.2012.112","article-title":"Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism","volume":"27","author":"Al","year":"2012","journal-title":"Oman Med J"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/humrep\/dew328","article-title":"Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome","volume":"32","author":"Handelsman","year":"2017","journal-title":"Hum Reprod"},{"key":"R24-20260109","first-page":"2867","article-title":"The application value of anti m\u00fcllerian hormone and free testosterone index in the diagnosis of polycystic ovary syndrome","volume":"28","author":"Shen","year":"2018","journal-title":"Chin J Health Lab Technol"},{"key":"R25-20260109","first-page":"33","article-title":"Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome","volume":"40","author":"Nadaraja","year":"2018","journal-title":"Malays J Pathol"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"e0203129","DOI":"10.1371\/journal.pone.0203129","article-title":"Threshold value of anti-mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS One"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/jcm9061831","article-title":"The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents","volume":"9","author":"Khashchenko","year":"2020","journal-title":"J Clin Med"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1515\/cclm-2019-1059","article-title":"Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome","volume":"58","author":"Evliyaoglu","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4103\/ijmr.IJMR_4608_20","article-title":"Serum anti-m\u00fcllerian hormone: A potential biomarker for polycystic ovary syndrome","volume":"158","author":"Halder","year":"2023","journal-title":"Indian J Med Res"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ejendo\/lvad055","article-title":"Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis","volume":"188","author":"Kiconco","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"R32-20260109","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1038\/s41598-018-22176-1","article-title":"Salivary and serum androgens with anti-m\u00fcllerian hormone measurement for the diagnosis of polycystic ovary syndrome","volume":"8","author":"Sathyapalan","year":"2018","journal-title":"Sci Rep"},{"key":"R33-20260109","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0042-1757445","article-title":"Free-androgen index in women with polycystic ovarian syndrome: A meta-analysis","volume":"13","author":"Patil","year":"2023","journal-title":"J Health Allied Sci NU"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_306_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:13Z","timestamp":1786647613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_306_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_306_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"2024-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}